294 related articles for article (PubMed ID: 9361105)
1. Follicular dendritic cell sarcoma complicated by hyaline-vascular type Castleman's disease in a schizophrenic patient.
Katano H; Kaneko K; Shimizu S; Saito T; Irié T; Mori S
Pathol Int; 1997 Oct; 47(10):703-6. PubMed ID: 9361105
[TBL] [Abstract][Full Text] [Related]
2. Development of follicular dendritic cell sarcoma in hyaline-vascular Castleman's disease of the nasopharynx: tracing its evolution by sequential biopsies.
Chan AC; Chan KW; Chan JK; Au WY; Ho WK; Ng WM
Histopathology; 2001 Jun; 38(6):510-8. PubMed ID: 11422494
[TBL] [Abstract][Full Text] [Related]
3. Follicular dendritic cell tumor and vascular neoplasm complicating hyaline-vascular Castleman's disease.
Chan JK; Tsang WY; Ng CS
Am J Surg Pathol; 1994 May; 18(5):517-25. PubMed ID: 8172326
[TBL] [Abstract][Full Text] [Related]
4. Epidermal growth factor receptor expression in follicular dendritic cells: a shared feature of follicular dendritic cell sarcoma and Castleman's disease.
Sun X; Chang KC; Abruzzo LV; Lai R; Younes A; Jones D
Hum Pathol; 2003 Sep; 34(9):835-40. PubMed ID: 14562277
[TBL] [Abstract][Full Text] [Related]
5. Transformation of Castleman's disease into follicular dendritic cell sarcoma, presenting as an asymptomatic intra-abdominal mass.
Hwang SO; Lee TH; Bae SH; Cho HD; Choi KH; Park SH; Kim CH; Kim SJ
Korean J Gastroenterol; 2013 Aug; 62(2):131-4. PubMed ID: 23981949
[TBL] [Abstract][Full Text] [Related]
6. A chromosomal abnormality in hyaline vascular Castleman's disease: evidence for clonal proliferation of dysplastic stromal cells.
Pauwels P; Dal Cin P; Vlasveld LT; Aleva RM; van Erp WF; Jones D
Am J Surg Pathol; 2000 Jun; 24(6):882-8. PubMed ID: 10843293
[TBL] [Abstract][Full Text] [Related]
7. Angiomyoid and follicular dendritic cell proliferative lesions in Castleman's disease of hyaline-vascular type: a study of 10 cases.
Lin O; Frizzera G
Am J Surg Pathol; 1997 Nov; 21(11):1295-306. PubMed ID: 9351567
[TBL] [Abstract][Full Text] [Related]
8. Follicular dendritic sarcoma within a focus of Castleman's disease. Serial FDG PET/CT in the follow up of recurrence with histopathologic confirmation.
Iagaru A; Mari C; Sam Gambhir S
Rev Esp Med Nucl; 2007; 26(1):40-5. PubMed ID: 17286947
[TBL] [Abstract][Full Text] [Related]
9. Cytologic demonstration of "dysplastic" follicular dendritic cells in a case of hyaline-vascular Castleman's disease.
Taylor GB; Smeeton IW
Diagn Cytopathol; 2000 Apr; 22(4):230-4. PubMed ID: 10787143
[TBL] [Abstract][Full Text] [Related]
10. Follicular dendritic cell sarcoma. Clinicopathologic analysis of 17 cases suggesting a malignant potential higher than currently recognized.
Chan JK; Fletcher CD; Nayler SJ; Cooper K
Cancer; 1997 Jan; 79(2):294-313. PubMed ID: 9010103
[TBL] [Abstract][Full Text] [Related]
11. Follicular dendritic cell sarcoma aggravated by hyaline-vascular Castleman's disease in association with paraneoplastic pemphigus: study of the tumor and successful treatment.
Wang J; Wang X; Xu J; Song P
An Bras Dermatol; 2019; 94(5):578-581. PubMed ID: 31777359
[TBL] [Abstract][Full Text] [Related]
12. Increased expression of vascular endothelial growth factor (VEGF) in Castleman's disease: proposed pathomechanism of vascular proliferation in the affected lymph node.
Nishi J; Maruyama I
Leuk Lymphoma; 2000 Jul; 38(3-4):387-94. PubMed ID: 10830746
[TBL] [Abstract][Full Text] [Related]
13. Castleman's disease. Differences in follicular dendritic network in the hyaline vascular and plasma cell variants.
Nguyen DT; Diamond LW; Hansmann ML; Alavaikko MJ; Schröder H; Fellbaum C; Fischer R
Histopathology; 1994 May; 24(5):437-43. PubMed ID: 8088715
[TBL] [Abstract][Full Text] [Related]
14. Expression of ICAM-1, VCAM-1 and ELAM-1 in angiofollicular lymph node hyperplasia (Castleman's disease): evidence for dysplasia of follicular dendritic reticulum cells.
Ruco LP; Gearing AJ; Pigott R; Pomponi D; Burgio VL; Cafolla A; Baiocchini A; Baroni CD
Histopathology; 1991 Dec; 19(6):523-8. PubMed ID: 1723957
[TBL] [Abstract][Full Text] [Related]
15. Castleman's disease associated with myasthenia gravis.
Day JR; Bew D; Ali M; Dina R; Smith PL
Ann Thorac Surg; 2003 May; 75(5):1648-50. PubMed ID: 12735602
[TBL] [Abstract][Full Text] [Related]
16. Cellular localisation of HHV-8 in Castleman's disease: is there a link with lymph node vascularity?
O'Leary J; Kennedy M; Howells D; Silva I; Uhlmann V; Luttich K; Biddolph S; Lucas S; Russell J; Bermingham N; O'Donovan M; Ring M; Kenny C; Sweeney M; Sheils O; Martin C; Picton S; Gatter K
Mol Pathol; 2000 Apr; 53(2):69-76. PubMed ID: 10889905
[TBL] [Abstract][Full Text] [Related]
17. Expression of EGFR and follicular dendritic markers in lymphoid follicles from patients with Castleman's disease.
Lee J; Ban JY; Won KY; Kim GY; Lim SJ; Lee S; Kim YW; Park YK; Lee SS
Oncol Rep; 2008 Oct; 20(4):851-6. PubMed ID: 18813826
[TBL] [Abstract][Full Text] [Related]
18. HHV-8 is not associated with follicular dendritic cell tumours.
Nayler SJ; Taylor L; Cooper K
Mol Pathol; 1998 Jun; 51(3):168-70. PubMed ID: 9850342
[TBL] [Abstract][Full Text] [Related]
19. [Intrahepatic sarcoma of the follicular dendritic cells].
Fritzsche FR; Bode B; Thies S; Donati OF; Schiesser M; Clavien PA; Jochum W
Pathologe; 2010 Mar; 31(2):153-6. PubMed ID: 19565242
[TBL] [Abstract][Full Text] [Related]
20. Castleman's disease associated with follicular dendritic cell sarcoma and myasthenia gravis.
Westphal FL; Lima LC; Santana LC; Netto JC; Amaral VC; Silva Mdos S
J Bras Pneumol; 2010; 36(6):819-23. PubMed ID: 21225186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
